BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+13.01%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.91T
AUM Growth
+$437B
(+13%)
Cap. Flow
+$36.3B
Cap. Flow
% of AUM
0.93%
Top 10 Holdings %
Top 10 Hldgs %
22.4%
Holding
5,487
New
93
Increased
3,052
Reduced
1,506
Closed
171
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.56B |
| 2 |
Uber
UBER
|
+$2.21B |
| 3 |
Apple
AAPL
|
+$2.11B |
| 4 |
Amazon
AMZN
|
+$2.1B |
| 5 |
Microsoft
MSFT
|
+$1.99B |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$5.15B |
| 2 |
VMW
VMware, Inc
VMW
|
+$2.9B |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$2.56B |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$1.72B |
| 5 |
Danaher
DHR
|
+$1.11B |
Sector Composition
| 1 | Technology | 27.22% |
| 2 | Healthcare | 12.82% |
| 3 | Financials | 12.11% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4326
CF Bankshares
CFBK
$162M
| $214K | ﹤0.01% |
10,985
-124
| -1% | -$2.42K |
|
4327
China Yuchai International
CYD
$1.42B
| $214K | ﹤0.01% |
25,561
-35,930
| -58% | -$301K |
|
4328
Westwater Resources
WWR
$59.6M
| $211K | ﹤0.01% |
374,307
| – | – |
|
4329
Rani Therapeutics
RANI
$24.2M
| $211K | ﹤0.01% |
63,583
| – | – |
|
4330
Electromed
ELMD
$209M
| $211K | ﹤0.01% |
19,308
-407
| -2% | -$4.44K |
|
4331
Koss Corp
KOSS
$54.1M
| $209K | ﹤0.01% |
62,532
-120
| -0.2% | -$402 |
|
4332
Lipocine
LPCN
$15.9M
| $209K | ﹤0.01% |
74,846
| – | – |
|
4333
GSI Technology
GSIT
$96.6M
| $206K | ﹤0.01% |
78,035
-473
| -0.6% | -$1.25K |
|
4334
Vanguard S&P 500 Growth ETF
VOOG
$19.8B
| $204K | ﹤0.01% |
752
| – | – |
|
|
SJT
4335
San Juan Basin Royalty Trust
SJT
$269M
| $204K | ﹤0.01% |
40,064
+4,833
| +14% | +$24.6K |
|
4336
Oramed Pharmaceuticals
ORMP
$99.6M
| $203K | ﹤0.01% |
87,758
-1,040
| -1% | -$2.4K |
|
4337
BeyondSpring
BYSI
$75.4M
| $202K | ﹤0.01% |
224,285
-11,542
| -5% | -$10.4K |
|
4338
IGC Pharma
IGC
$36.7M
| $201K | ﹤0.01% |
717,884
| – | – |
|
4339
Mega Matrix
MPU
$96.4M
| $201K | ﹤0.01% |
142,416
-730
| -0.5% | -$1.03K |
|
4340
DURECT Corp
DRRX
$59.3M
| $200K | ﹤0.01% |
338,855
-686
| -0.2% | -$405 |
|
4341
Euroseas
ESEA
$442M
| $199K | ﹤0.01% |
7,868
| – | – |
|
|
AXDX
4342
DELISTED
Accelerate Diagnostics
AXDX
| $199K | ﹤0.01% |
50,842
| – | – |
|
4343
Cumberland Pharmaceuticals
CPIX
$51.3M
| $199K | ﹤0.01% |
110,990
| – | – |
|
4344
Lightbridge
LTBR
$365M
| $198K | ﹤0.01% |
61,625
-332
| -0.5% | -$1.07K |
|
4345
Vanguard Mid-Cap ETF
VO
$88.6B
| $197K | ﹤0.01% |
846
-51
| -6% | -$11.9K |
|
4346
Aligos Therapeutics
ALGS
$75.6M
| $197K | ﹤0.01% |
11,846
-32
| -0.3% | -$531 |
|
4347
enVVeno Medical
NVNO
$15.1M
| $196K | ﹤0.01% |
38,141
+7,062
| +23% | +$36.3K |
|
4348
Dominari Holdings
DOMH
$108M
| $195K | ﹤0.01% |
75,275
| – | – |
|
4349
Vanguard Communication Services ETF
VOX
$5.87B
| $195K | ﹤0.01% |
1,656
+1,392
| +527% | +$164K |
|
4350
DarioHealth
DRIO
$17M
| $194K | ﹤0.01% |
5,631
+236
| +4% | +$8.12K |
|